Future Parkinson Caregivers - Preventive E-Mental Health Support Program for Family Members of Parkinson's Disease Patients

Not Applicable

• Conditions: Relatives of patients with Parkinson's disease with only slight impairment (G20.0) and who are not in need of care; G20.0

• Registration Number: DRKS00025247
• Lead Sponsor: niversitätsklinikum Gießen und Marburg, Klinik für Neurologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-05-18
• Study Completion: 2022-11-21
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Relatives: partners of Parkinson's patients of any gender living with at least one person with Parkinson's; age = 18 years; not (yet) caring; relatives must be able to give consent and sign a consent form; relatives must have a good knowledge of German; cognitive health (telephone screening by MoCA); openness to preventive empowerment; willingness to use telemedicine; internet connection, availability of a PC or tablet.

Patients: Male and female patients* with clinical diagnosis of idiopathic or atypical Parkinson's disease according to MDS criteria; age = 18 years; no care degree or no care by a nursing service; Hoehn & Yahr stage I - II (OFF-state); patients must be able to give consent and sign an informed consent form.

Exclusion Criteria

Relatives: own need for care (i.e., existing care level); major depression (BDI II = 29 points); expected incompliance regarding study participation.

Patient: Hoehn & Yahr stage = 3 (OFF-state); current care needs: care level and care by a nursing service; dementia diagnosed by a neurologist.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility of the intervention (participation in the 3 intervention sessions; intervention diary: mood and motivation before and after each session as well as overall evaluation of the e-mental health solution and intervention after the last session (T1); subjective benefit (Credibility/Expectancy Questionnaire (CEQ; T1) and qualitative interview at T1 and T2); manual adherence) - survey via online consultation or questionnaires sent by post.

Secondary Outcome Measures

Name	Time	Method
Assessment at all three measurement points: Stress situation of family members with Parkinson's disease (PDCB); depression (BDI-II); health-related quality of life (EQ-5D); coping (CISS); health-related resources and self-management skills (FERUS); therapy expectation and evaluation (PATHEV; T1 and T2 only).